Precigen, Inc. (PGEN)
4.24
-0.04
(-0.93%)
USD |
NASDAQ |
May 22, 16:00
4.24
0.00 (0.00%)
After-Hours: 20:00
Precigen EPS Diluted (Quarterly) : -0.0224 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Clene, Inc. | -0.6949 |
| Abeona Therapeutics, Inc. | -0.3016 |
| ImmunityBio, Inc. | -0.6162 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| MiMedx Group, Inc. | -0.0732 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.929M |
| Revenue (Quarterly) | 23.25M |
| Total Expenses (Quarterly) | 31.18M |
| Enterprise Value | 1.554B |
| Gross Profit Margin (Quarterly) | 87.63% |
| Profit Margin (Quarterly) | -34.10% |
| Earnings Yield | -29.20% |
| Normalized Earnings Yield | -23.23 |